Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.

Detailed price information for Vir Biotechnology Inc (VIR-Q) from The Globe and Mail including charting and trades.

US-based Accel Leaders Fund is expected to join Rapido’s ongoing $550-600 million financing round, led by Dutch investor ...

Developer and major GOP donor Larry Mizel has reached a $25 million deal to resolve a pension fund’s challenge to the $4.9 billion sale of his real estate empire to Japanese homebuilder Sekisui House ...

CRD VI (Directive (EU) 2024/1619) introduces a new harmonized regime requiring banks to notify competent authorities of, and in some cases receive prior approval for ...

Billionaire trader Leo KoGuan revealed he just bought 1 million shares of Nvidia , expanding his artificial intelligence bet beyond Tesla — the electric vehicle maker that helped make him one of its ...

Agios Pharmaceuticals focuses on the development and commercialization of medicines targeting cellular metabolism, including PYRUKYND (mitapivat) for hemolytic anemias. The firm generates revenue ...

If you've ever filled a large gap with caulk, only to watch it pull away from the edges as it dries, you've experienced one of the primary reasons that backer rod exists. Backer rod does more than ...

Pelagic Partners is ready to pull the trigger on more vessel acquisitions through its new credit fund, MareVia. MareVia — part of the Cypriot shipowner and shipping fund manager’s London-based Pelagic ...

XP Inc. is a leading financial services provider in Brazil, operating at scale with a diversified suite of investment and banking products. The company uses a technology-driven open platform to ...